BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...Cancer company Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) hired Erick Lucera as CFO. He was CFO of Valeritas...
BioCentury | Jun 26, 2015
Company News

Management tracks

...Inhalable therapies company Pulmatrix Inc. (NASDAQ:PULM) hired William Duke as CFO. He was CFO at Valeritas Inc....
BioCentury | Apr 6, 2015
Finance

Fundamental rally

...Technologies Inc. 2/27/15 Up to $60M Mkt (tools) 3SBio Inc. (HKSE) 2/20/15 TBD Mkt (drug) Valeritas Inc....
BioCentury | Mar 16, 2015
Financial News

Valeritas amends IPO

...million Shares: 5 million Price: $14-$16 Underwriters: Piper Jaffray; Leerink Partners; Oppenheimer Overallotment: 750,000 Note: Valeritas...
BioCentury | Feb 16, 2015
Financial News

Valeritas proposes IPO

...Up to $90 million Shares: TBD Price: TBD Underwriters: Piper Jaffray; Leerink Partners; Oppenheimer Note: Valeritas...
BioCentury | Sep 20, 2014
Financial News

USVP to raise $275M 11th fund

...Cleave Biosciences Inc. (Burlingame, Calif.) and Effector Therapeutics Inc. (San Diego, Calif.); medical device play Valeritas Inc....
BioCentury | Jun 17, 2013
Financial News

Valeritas completes venture financing

Valeritas Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Date completed: 6/4/13 Type: Venture financing Raised: Not disclosed Investor: Capital Royalty Note: The company closed a structured debt financing for up to $100 million. The company...
BioCentury | Sep 19, 2011
Financial News

Valeritas completes venture financing

Valeritas Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Date completed: 9/12/11 Type: Venture financing Raised: $150 million Investors: Welsh, Carson, Anderson & Stowe; MPM Capital; Pitango; Abingworth Management; Advanced Technology Ventures; Onset; HLM Venture Partners;...
BioCentury | Sep 19, 2011
Company News

Valeritas board of directors update

Valeritas Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Appointed: Daniel Pelak, senior industry executive at Welsh, Carson, Anderson & Stowe as chairman WIR Staff...
BioCentury | Sep 13, 2011
Financial News

Valeritas raises $150M in series C

...Medical device company Valeritas Inc. (Bridgewater, N.J.) raised $150 million in a series C round led by...
...HLM Venture Partners; Kaiser Permanente Ventures; MPM Capital; Onset; and Pitango Venture Capital also participated. Valeritas'...
...patients with diabetes. WCAS's Daniel Pelak will replace MPM Capital's Vaughn Kailian as chairman of Valeritas'...
Items per page:
1 - 10 of 14
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...Cancer company Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) hired Erick Lucera as CFO. He was CFO of Valeritas...
BioCentury | Jun 26, 2015
Company News

Management tracks

...Inhalable therapies company Pulmatrix Inc. (NASDAQ:PULM) hired William Duke as CFO. He was CFO at Valeritas Inc....
BioCentury | Apr 6, 2015
Finance

Fundamental rally

...Technologies Inc. 2/27/15 Up to $60M Mkt (tools) 3SBio Inc. (HKSE) 2/20/15 TBD Mkt (drug) Valeritas Inc....
BioCentury | Mar 16, 2015
Financial News

Valeritas amends IPO

...million Shares: 5 million Price: $14-$16 Underwriters: Piper Jaffray; Leerink Partners; Oppenheimer Overallotment: 750,000 Note: Valeritas...
BioCentury | Feb 16, 2015
Financial News

Valeritas proposes IPO

...Up to $90 million Shares: TBD Price: TBD Underwriters: Piper Jaffray; Leerink Partners; Oppenheimer Note: Valeritas...
BioCentury | Sep 20, 2014
Financial News

USVP to raise $275M 11th fund

...Cleave Biosciences Inc. (Burlingame, Calif.) and Effector Therapeutics Inc. (San Diego, Calif.); medical device play Valeritas Inc....
BioCentury | Jun 17, 2013
Financial News

Valeritas completes venture financing

Valeritas Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Date completed: 6/4/13 Type: Venture financing Raised: Not disclosed Investor: Capital Royalty Note: The company closed a structured debt financing for up to $100 million. The company...
BioCentury | Sep 19, 2011
Financial News

Valeritas completes venture financing

Valeritas Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Date completed: 9/12/11 Type: Venture financing Raised: $150 million Investors: Welsh, Carson, Anderson & Stowe; MPM Capital; Pitango; Abingworth Management; Advanced Technology Ventures; Onset; HLM Venture Partners;...
BioCentury | Sep 19, 2011
Company News

Valeritas board of directors update

Valeritas Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Appointed: Daniel Pelak, senior industry executive at Welsh, Carson, Anderson & Stowe as chairman WIR Staff...
BioCentury | Sep 13, 2011
Financial News

Valeritas raises $150M in series C

...Medical device company Valeritas Inc. (Bridgewater, N.J.) raised $150 million in a series C round led by...
...HLM Venture Partners; Kaiser Permanente Ventures; MPM Capital; Onset; and Pitango Venture Capital also participated. Valeritas'...
...patients with diabetes. WCAS's Daniel Pelak will replace MPM Capital's Vaughn Kailian as chairman of Valeritas'...
Items per page:
1 - 10 of 14